Cost-effectiveness of treating schizophrenia with atypical antipsychotics

被引:0
|
作者
Lewis, M [1 ]
Frangou, S [1 ]
机构
[1] Inst Psychiat, Sect Neurobiol Psychosis, London, England
关键词
D O I
10.1016/S0920-9964(03)80332-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:338 / 339
页数:2
相关论文
共 50 条
  • [1] Cost-effectiveness of treating schizophrenia with atypical antipsychotics
    Lewis, M
    Frangou, S
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 172 - 172
  • [2] Cost-effectiveness of atypical antipsychotics in chronic schizophrenia
    Amin, S
    HOSPITAL MEDICINE, 1999, 60 (06): : 410 - 413
  • [3] Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK
    Davies, Andrew
    Vardeva, Kawitha
    Loze, Jean-Yves
    L'Italien, Gilbert J.
    Sennfalt, Karin
    van Baardewijk, Marc
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3275 - 3285
  • [4] Cost-effectiveness of atypical antipsychotics in the CATIE schizophrenia trial
    Rosenheck, RA
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S32 - S32
  • [5] COST-EFFECTIVENESS OF ATYPICAL VERSUS TYPICAL ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Krysanov, I
    Tsfasman, F. M.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [6] COST-EFFECTIVENESS OF SERTINDOLE AMONG ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA IN SOUTH KOREA
    Kim, B. R. M.
    Lee, H. J.
    Park, B. H.
    Yang, B. M.
    Lee, T. J.
    VALUE IN HEALTH, 2010, 13 (07) : A554 - A554
  • [7] LONG-TERM COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS FOR SCHIZOPHRENIA IN THE UNITED STATES
    Rajagopalan, K.
    O'Day, K.
    Meyer, K.
    Pikalov, A. A., III
    Loebel, A.
    VALUE IN HEALTH, 2012, 15 (04) : A87 - A87
  • [8] Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia
    Obradovic, M.
    Mrhar, A.
    Kos, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (12) : 1979 - 1988
  • [9] COST-EFFECTIVENESS OF INJECTABLE ATYPICAL LONG-ACTING ANTIPSYCHOTICS FOR CHRONIC SCHIZOPHRENIA IN POLAND
    Hemels, M.
    Einarson, T. R.
    Zilbershtein, R.
    Schubert, A.
    Skrzekowska-Baran, I
    Van Impe, K.
    VALUE IN HEALTH, 2013, 16 (07) : A548 - A548
  • [10] Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
    O'Day, Ken
    Rajagopalan, Krithika
    Meyer, Kellie
    Pikalov, Andrei
    Loebel, Antony
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 459 - 470